FP/CP say Livewell Canada researching CBD products
2018-10-01 07:49 ET - In the News
See In the News (C-LVWL) Livewell Canada Inc
The Financial Post reports in its Saturday, Sept. 29, edition that cannabidiol or CBD, a compound derived from cannabis that does not get you high, may one day be available on grocery or pharmacy shelves, instead of in tightly-regulated pot shops. A Canadian Press dispatch to the Post reports that lawyer Trina Fraser, who advises weed industry, says globally, the market for CBD could be "massive." Research evidence, as for cannabis overall, is slim but the anecdotal buzz about CBD is building. Products with CBD in Canada are illegal unless authorized for medical purposes.When Canada legalizes pot for recreational use on Oct. 17, products with CBD will be regulated similarly to marijuana products. The Post says restrictions on CBD are showing signs of easing, particularly in the United States, and the growth projections for the market are now dramatically higher than they were a year ago.
It could outpace the rest of the cannabis market to reach $22-billion by 2022, according to its recent report. Coca-Cola has expressed interest in CBD. Reports said it was in talks with Aurora Cannabis. Canopy Growth's Canopy Rivers is invested in Livewell Canada, which is researching CBD and plans to develop CBD products.
© 2018 Canjex Publishing Ltd. All rights reserved.
Posts
